» Articles » PMID: 23261775

The Inflammasome: Pathways Linking Psychological Stress, Depression, and Systemic Illnesses

Overview
Publisher Elsevier
Date 2012 Dec 25
PMID 23261775
Citations 237
Authors
Affiliations
Soon will be listed here.
Abstract

Stress is a common occurrence in everyday life and repeated or traumatic stress can be a precipitating factor for illnesses of the central nervous system, as well as peripheral organ systems. For example, severe or long-term psychological stress can not only induce depression, a leading illness worldwide, but can also cause psychosomatic diseases such as asthma and rheumatoid arthritis. Related key questions include how psychological stress influences both brain and peripheral systems, and what detection mechanisms underlie these effects? A clue is provided by the discovery of the pathways underlying the responses to host "danger" substances that cause systemic diseases, but can also contribute to depression. The inflammasome is a protein complex that can detect diverse danger signals and produce the accompanying immune-inflammatory reactions. Interestingly, the inflammasome can detect not only pathogen-associated molecules, but also cell damage-associated molecules such as ATP. Here, we propose a new inflammasome hypothesis of depression and related comorbid systemic illnesses. According to this hypothesis, the inflammasome is a central mediator by which psychological and physical stressors can contribute to the development of depression, and as well as a bridge to systemic diseases. This hypothesis includes an explanation for how psychological stress can influence systemic diseases, and conversely how systemic diseases can lead to psychiatric illnesses. The evidence suggests that the inflammasome may be a new target for the development of treatments for depression, as well as psychosomatic and somato-psycho diseases.

Citing Articles

Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.

Lucido M, Dunlop B Brain Sci. 2025; 15(2).

PMID: 40002494 PMC: 11853532. DOI: 10.3390/brainsci15020161.


Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential.

Zha T, Fang X, Wan J, Chen X, Lin J, Chen Q Biomolecules. 2025; 15(2).

PMID: 40001468 PMC: 11852603. DOI: 10.3390/biom15020165.


Global trends of purinergic receptors and depression: A bibliometric analysis from 2003 to 2023.

Huang B, Chen W, Peng C, Shen X, Xue J, Yan C World J Psychiatry. 2025; 15(2):102344.

PMID: 39974485 PMC: 11758036. DOI: 10.5498/wjp.v15.i2.102344.


Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels.

Miura A, Yamanashi T, Kajitani N, Fukuda S, Tsunetomi K, Matsuo R Yonago Acta Med. 2025; 68(1):58-67.

PMID: 39968118 PMC: 11831044. DOI: 10.33160/yam.2025.02.007.


Efficacy of Transcranial Direct Current Stimulation (tDCS) on Neuropsychiatric Symptoms in Multiple Sclerosis (MS)-A Review and Insight into Possible Mechanisms of Action.

Chmiel J, Stepien-Slodkowska M J Clin Med. 2025; 13(24.

PMID: 39768715 PMC: 11728448. DOI: 10.3390/jcm13247793.


References
1.
Pariante C, Pearce B, Pisell T, Sanchez C, Po C, Su C . The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999; 140(9):4359-66. DOI: 10.1210/endo.140.9.6986. View

2.
Besnard A, Guillou N, Tschopp J, Erard F, Couillin I, Iwakura Y . NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy. 2011; 66(8):1047-57. DOI: 10.1111/j.1398-9995.2011.02586.x. View

3.
Gasse P, Riteau N, Charron S, Girre S, Fick L, Petrilli V . Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med. 2009; 179(10):903-13. DOI: 10.1164/rccm.200808-1274OC. View

4.
Sapolsky R, Romero L, Munck A . How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21(1):55-89. DOI: 10.1210/edrv.21.1.0389. View

5.
Simen B, Duman C, Simen A, Duman R . TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry. 2006; 59(9):775-85. DOI: 10.1016/j.biopsych.2005.10.013. View